Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics

Since the emergence of the SARS-CoV-2 pandemic in 2019, it has remained a significant global threat, especially with the newly evolved variants. Despite the presence of different COVID-19 vaccines, the discovery of proper antiviral therapeutics is an urgent necessity. Nature is considered as a histo...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhadrami, Hani A., Sayed, Ahmed M., Hassan, Hossam M., Youssif, Khayrya A., Gaber, Yasser, Moatasim, Yassmin, Kutkat, Omnia, Mostafa, Ahmed, Ali, Mohamed Ahmed, Rateb, Mostafa E., Abdelmohsen, Usama Ramadan, Gamaleldin, Noha M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150330/
https://www.ncbi.nlm.nih.gov/pubmed/34066998
http://dx.doi.org/10.3390/antibiotics10050542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150330/
https://www.ncbi.nlm.nih.gov/pubmed/34066998
http://dx.doi.org/10.3390/antibiotics10050542

Ejemplares similares